The Serum Concentration of Anti-Aging Proteins, Sirtuin1 and αKlotho in Patients with End-Stage Kidney Disease on Maintenance Hemodialysis

References

• Watroba M, Szukiewicz D. The role of sirtuins in aging and age-related diseases. Adv Med Sci. 2016;61(1):52–62. doi:10.1016/j.advms.2015.09.00326521204
   PubMed Web of Science ®Google Scholar
• Landry J, Sutton A, Tafrov ST, et al. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A. 2000;97(11):5807–5811. doi:10.1073/pnas.11014829710811920
   PubMed Web of Science ®Google Scholar
• Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun. 2000;273(2):793–798. doi:10.1006/bbrc.2000.300010873683
   PubMed Web of Science ®Google Scholar
• Carafa V, Rotili D, Forgione M, et al. Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics. 2016;8:61. doi:10.1186/s13148-016-0224-327226812
   PubMed Web of Science ®Google Scholar
• Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305(5682):390–392. doi:10.1126/science.109919615205477
   PubMed Web of Science ®Google Scholar
• Erben RG. Update on FGF23 and Klotho signaling. Mol Cell Endocrinol. 2016;432:56–65. doi:10.1016/j.mce.2016.05.00827178987
   PubMed Web of Science ®Google Scholar
• Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45–51. doi:10.1038/362859363890
   PubMed Web of Science ®Google Scholar
• Xu Y, Sun Z. Molecular basis of Klotho: from gene to function in aging. Endocr Rev. 2015;36(2):174–193. doi:10.1210/er.2013-107925695404
   PubMed Web of Science ®Google Scholar
• Yacoub R, Lee K, He JC. The role of SIRT1 in diabetic kidney disease. Front Endocrinol (Lausanne). 2014;5:166. doi:10.3389/fendo.2014.0016625346724
   PubMed Web of Science ®Google Scholar
• Aditya R, Kiran AR, Varma DS, Vemuri R, Gundamaraju R. A review on SIRtuins in diabetes. Curr Pharm Des. 2017;23(16):2299–2307. doi:10.2174/138161282366617012515333428128062
   PubMed Web of Science ®Google Scholar
• Yue XG, Yang ZG, Zhang Y, Qin GJ, Liu F. Correlations between SIRT1 gene polymorphisms and diabetic kidney disease. R Soc Open Sci. 2018;5(6):171871. doi:10.1098/rsos.17187130110438
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wei J, Hou X, et al. SIRT1 rs10823108 and FOXO1 rs17446614 responsible for genetic susceptibility to diabetic nephropathy. Sci Rep. 2017;7(1):10285. doi:10.1038/s41598-017-10612-728860538
   PubMed Web of Science ®Google Scholar
• Kalaitzidis RG, Duni A, Siamopoulos KC. Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease. Int Urol Nephrol. 2016;48(10):1657–1666. doi:10.1007/s11255-016-1325-927215557
   PubMed Web of Science ®Google Scholar
• Zhou L, Mo H, Miao J, et al. Klotho ameliorates kidney injury and fibrosis and normalizes blood pressure by targeting the renin-angiotensin system. Am J Pathol. 2015;185(12):3211–3223. doi:10.1016/j.ajpath.2015.08.00426475416
   PubMed Web of Science ®Google Scholar
• Gao D, Zuo Z, Tian J, et al. Activation of SIRT1 attenuates klotho deficiency-induced arterial stiffness and hypertension by enhancing AMP-activated protein kinase activity. Hypertension. 2016;68(5):1191–1199. doi:10.1161/HYPERTENSIONAHA.116.0770927620389
   PubMed Web of Science ®Google Scholar
• Workgroup KD. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–S153.
   Web of Science ®Google Scholar
• Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64. doi:10.1016/j.echo.2018.06.00430282592
   PubMed Web of Science ®Google Scholar
• Katsi VK, Pavlidis AN, Liakos CI, et al. The tree of sirtuins and the garden of cardiovascular youth. Curr Vasc Pharmacol. 2016;14(1):80–87. doi:10.2174/157016111366615091609390226374109
   PubMed Web of Science ®Google Scholar
• Zhong Y, Chen AF, Zhao J, Gu YJ, Fu GX. Serum levels of cathepsin D, sirtuin1, and endothelial nitric oxide synthase are correlatively reduced in elderly healthy people. Aging Clin Exp Res. 2016;28(4):641–645. doi:10.1007/s40520-015-0472-726462844
   PubMed Web of Science ®Google Scholar
• Xiao NM, Zhang YM, Zheng Q, Gu J. Klotho is a serum factor related to human aging. Chin Med J (Engl). 2004;117(5):742–747.15161545
   PubMed Web of Science ®Google Scholar
• Lindberg K, Amin R, Moe OW, et al. The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol. 2014;25(10):2169–2175. doi:10.1681/ASN.201311120924854271
   PubMed Web of Science ®Google Scholar
• Lindberg K, Olauson H, Amin R, et al. Arterial klotho expression and FGF23 effects on vascular calcification and function. PLoS One. 2013;8(4):e60658. doi:10.1371/journal.pone.006065823577141
   PubMed Web of Science ®Google Scholar
• Marcais C, Maucort-boulch D, Drai J, et al. Circulating Klotho associates with cardiovascular morbidity and mortality during hemodialysis. J Clin Endocrinol Metab. 2017;102(9):3154–3161. doi:10.1210/jc.2017-0010428402487
   PubMed Web of Science ®Google Scholar
• Kakareko K, Rydzewska-rosolowska A, Brzosko S, et al. The effect of nephrectomy on Klotho, FGF-23 and bone metabolism. Int Urol Nephrol. 2017;49(4):681–688. doi:10.1007/s11255-017-1519-928130714
   PubMed Web of Science ®Google Scholar
• Kedenko L, Lamina C, Kedenko I, et al. Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort. BMC Med Genet. 2014;15:112. doi:10.1186/s12881-014-0112-725273948
   PubMed Web of Science ®Google Scholar
• Shimoyama Y, Mitsuda Y, Tsuruta Y, Suzuki K, Hamajima N, Niwa T. SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients. J Ren Nutr. 2012;22(1):114–119. doi:10.1053/j.jrn.2011.10.02522200427
   PubMed Web of Science ®Google Scholar
• Tucker PS, Scanlan AT, Dalbo VJ. Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease. Oxid Med Cell Longev. 2015;2015:806358. doi:10.1155/2015/80635825861414
   PubMed Web of Science ®Google Scholar
• He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010;120(4):1056–1068. doi:10.1172/JCI4156320335659
   PubMed Web of Science ®Google Scholar
• Chuang PY, Xu J, Dai Y, et al. In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells. Am J Pathol. 2014;184(7):1940–1956. doi:10.1016/j.ajpath.2014.03.01624952428
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Wakino S, Simic P, et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med. 2013;19(11):1496–1504. doi:10.1038/nm.336324141423
   PubMed Web of Science ®Google Scholar
• Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res. 2011;2011:908185. doi:10.1155/2011/90818521949662
   PubMed Web of Science ®Google Scholar
• Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol. 2006;16(3):296–300. doi:10.1016/j.cub.2005.12.03816461283
   PubMed Web of Science ®Google Scholar
• Chander V, Chopra K. Protective effect of resveratrol, a polyphenolic phytoalexin on glycerol-induced acute renal failure in rat kidney. Ren Fail. 2006;28(2):161–169. doi:10.1080/0886022050053111216538975
   PubMed Web of Science ®Google Scholar
• Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb. 2010;17(5):431–435. doi:10.5551/jat.352520215708
   PubMed Web of Science ®Google Scholar
• Wicinski M, Malinowski B, Weclewicz MM, Grzesk E, Grzesk G. Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model. Exp Ther Med. 2017;13(5):2071–2078. doi:10.3892/etm.2017.418028565810
   PubMed Web of Science ®Google Scholar
• Qi MZ, Yao Y, Xie RL, et al. Intravenous Vitamin C attenuates hemorrhagic shock-related renal injury through the induction of SIRT1 in rats. Biochem Biophys Res Commun. 2018;501(2):358–364. doi:10.1016/j.bbrc.2018.04.11129673592
   PubMed Web of Science ®Google Scholar
• Olivares D, Perez-hernandez J, Forner MJ, et al. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis. Clin Sci (Lond). 2018;132(5):569–579. doi:10.1042/CS2017141029440621
   PubMed Web of Science ®Google Scholar
• Duman H, Bahceci I, Cinier G, Duman H, Bakirci EM, Cetin M. Left ventricular hypertrophy is associated with increased sirtuin level in newly diagnosed hypertensive patients. Clin Exp Hypertens. 2019;41(6):511–515. doi:10.1080/10641963.2018.151094630230925
   PubMed Web of Science ®Google Scholar
• Kiziltunc E, Kosem A, Ozkan C, et al. Serum Sirtuin 1, 3 and 6 levels in acute myocardial infarction patients. Arq Bras Cardiol. 2019;113(1):33–39. doi:10.5935/abc.2019011431291416
   PubMed Web of Science ®Google Scholar